UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 66

Sortiert nach

Surveillance of Resistance to Adamantanes among Influenza A(H3N2) and A(H1N1) Viruses Isolated Worldwide

The Journal of infectious diseases, 2007-07, Vol.196 (2), p.249-257

2007

Link zum Volltext

Verfügbarkeit prüfen

Surveillance for Neuraminidase Inhibitor Resistance among Human Influenza A and B Viruses Circulating Worldwide from 2004 to 2008

Antimicrobial Agents and Chemotherapy, 2008-09, Vol.52 (9), p.3284-3292

2008

Link zum Volltext

Verfügbarkeit prüfen

Incidence of adamantane resistance among influenza A (H3N2) viruses isolated worldwide from 1994 to 2005: a cause for concern

The Lancet (British edition), 2005-10, Vol.366 (9492), p.1175-1181

2005

Link zum Volltext

Verfügbarkeit prüfen

Cross-clade protective immune responses to influenza viruses with H5N1 HA and NA elicited by an influenza virus-like particle

PloS one, 2008-01, Vol.3 (1), p.e1501-e1501

2008

Link zum Volltext

Verfügbarkeit prüfen

Pathogenesis of emerging avian influenza viruses in mammals and the host innate immune response

Immunological reviews, 2008-10, Vol.225 (1), p.68-84

2008

Link zum Volltext

Verfügbarkeit prüfen

Transmission of Equine Influenza Virus to Dogs

Science (American Association for the Advancement of Science), 2005-10, Vol.310 (5747), p.482-485

2005

Link zum Volltext

Verfügbarkeit prüfen

A trivalent virus-like particle vaccine elicits protective immune responses against seasonal influenza strains in mice and ferrets

PloS one, 2009-06, Vol.4 (6), p.e6032-e6032

2009

Link zum Volltext

Verfügbarkeit prüfen

Development of adenoviral-vector-based pandemic influenza vaccine against antigenically distinct human H5N1 strains in mice

The Lancet (British edition), 2006-02, Vol.367 (9509), p.475-481

2006

Link zum Volltext

Verfügbarkeit prüfen

Polygenic virulence factors involved in pathogenesis of 1997 Hong Kong H5N1 influenza viruses in mice

Virus research, 2007-09, Vol.128 (1), p.159-163

2007

Link zum Volltext

Verfügbarkeit prüfen

Rapid Scaling Up of Covid-19 Diagnostic Testing in the United States — The NIH RADx Initiative

The New England journal of medicine, 2020-09, Vol.383 (11), p.1071-1077

2020

Link zum Volltext

Verfügbarkeit prüfen

A National Strategy for COVID-19: Testing, Surveillance, and Mitigation Strategies

JAMA : the journal of the American Medical Association, 2022-01, Vol.327 (3), p.213

2022

Link zum Volltext

Verfügbarkeit prüfen

A National Strategy for COVID-19 Medical Countermeasures: Vaccines and Therapeutics

JAMA : the journal of the American Medical Association, 2022-01, Vol.327 (3), p.215

2022

Link zum Volltext

Verfügbarkeit prüfen

United States of America Department of Health and Human Services support for advancing influenza vaccine manufacturing in the developing world

Vaccine, 2011-07, Vol.29 (S1), p.A48-A50

2011

Link zum Volltext

Verfügbarkeit prüfen

Testing, Surveillance, and Mitigation Strategies for COVID-19-Reply

JAMA : the journal of the American Medical Association, 2022-05, Vol.327 (18), p.1825

2022

Link zum Volltext

Verfügbarkeit prüfen

Detection of Molecular Markers of Antiviral Resistance in Influenza A (H5N1) Viruses Using a Pyrosequencing Method

Antimicrobial Agents and Chemotherapy, 2009-03, Vol.53 (3), p.1039-1047

2009

Link zum Volltext

Verfügbarkeit prüfen

Influenza Vaccine Manufacture: Keeping Up with Change

The Journal of infectious diseases, 2009-09, Vol.200 (6), p.835-837

2009

Link zum Volltext

Verfügbarkeit prüfen

Current testing systems are a barrier to achieving the 7-1-7 target for detection, notification, and response to public health threats

The Lancet global health, 2023-09, Vol.11 (9), p.e1340-e1340

2023

Link zum Volltext

Verfügbarkeit prüfen

The 100 Days Mission: how a new medical-countermeasures network can deliver equity and innovation

The Lancet (British edition), 2023-10, Vol.402 (10412), p.1507-1510

2023

Link zum Volltext

Verfügbarkeit prüfen

Adamantane resistance among influenza A viruses isolated early during the 2005-2006 influenza season in the United States

JAMA : the journal of the American Medical Association, 2006-02, Vol.295 (8), p.891

2006

Link zum Volltext

Verfügbarkeit prüfen

Influenza virus-like particles elicit broader immune responses than whole virion inactivated influenza virus or recombinant hemagglutinin

Vaccine, 2007-05, Vol.25 (19), p.3871-3878

2007

Link zum Volltext

Verfügbarkeit prüfen

Impact of glycosylation on the immunogenicity of a DNA-based influenza H5 HA vaccine

Virology (New York, N.Y.), 2003-04, Vol.308 (2), p.270-278

2003

Link zum Volltext

Verfügbarkeit prüfen

Safety and immunogenicity of influenza A(H5N1) vaccine stored up to twelve years in the National Pre-Pandemic Influenza Vaccine Stockpile (NPIVS)

Vaccine, 2019-01, Vol.37 (3), p.435-443

2019

Link zum Volltext

Verfügbarkeit prüfen

Seasonal influenza vaccination is associated with reduced risk of death among Medicare beneficiaries

Vaccine, 2021-12, Vol.39 (52), p.7569-7577

2021

Link zum Volltext

Verfügbarkeit prüfen

Meeting the Challenges of Sepsis in Severe Coronavirus Disease 2019: A Call to Arms

Open forum infectious diseases, 2023-01, Vol.10 (1), p.ofac645-ofac645

2023

Link zum Volltext

Verfügbarkeit prüfen

H5N1 VLP vaccine induced protection in ferrets against lethal challenge with highly pathogenic H5N1 influenza viruses

Vaccine, 2008-10, Vol.26 (42), p.5393-5399

2008

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 66

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(59)
Mit Volltextzugriff
(59)

Publikationsform

Sprache

Englisch
(66)
Japanisch
(11)

Erscheinungsjahr

n.n

Thema

Science & Technology
(48)
Life Sciences & Biomedicine
(34)
Humans
(30)
Animals
(18)
Vaccines
(17)
Influenza
(16)
Viruses
(16)
Immunology
(15)
Biological And Medical Sciences
(13)
Infectious Diseases
(12)
Microbiology
(12)
Pandemics
(11)
Vaccination
(11)
Influenza, Human - Prevention & Control
(10)
Influenza Vaccines - Immunology
(9)
Mice
(9)
Female
(8)
General & Internal Medicine
(8)
Infections
(8)
Influenza Virus
(8)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Surveillance of Resistance to Adamantanes among Influenza A(H3N2) and A(H1N1) Viruses Isolated Worldwide

Surveillance for Neuraminidase Inhibitor Resistance among Human Influenza A and B Viruses Circulating Worldwide from 2004 to 2008

Incidence of adamantane resistance among influenza A (H3N2) viruses isolated worldwide from 1994 to 2005: a cause for concern

Cross-clade protective immune responses to influenza viruses with H5N1 HA and NA elicited by an influenza virus-like particle

Pathogenesis of emerging avian influenza viruses in mammals and the host innate immune response

Transmission of Equine Influenza Virus to Dogs

A trivalent virus-like particle vaccine elicits protective immune responses against seasonal influenza strains in mice and ferrets

Development of adenoviral-vector-based pandemic influenza vaccine against antigenically distinct human H5N1 strains in mice

Polygenic virulence factors involved in pathogenesis of 1997 Hong Kong H5N1 influenza viruses in mice

Rapid Scaling Up of Covid-19 Diagnostic Testing in the United States — The NIH RADx Initiative

A National Strategy for COVID-19: Testing, Surveillance, and Mitigation Strategies

A National Strategy for COVID-19 Medical Countermeasures: Vaccines and Therapeutics

United States of America Department of Health and Human Services support for advancing influenza vaccine manufacturing in the developing world

Testing, Surveillance, and Mitigation Strategies for COVID-19-Reply

Detection of Molecular Markers of Antiviral Resistance in Influenza A (H5N1) Viruses Using a Pyrosequencing Method

Influenza Vaccine Manufacture: Keeping Up with Change

Current testing systems are a barrier to achieving the 7-1-7 target for detection, notification, and response to public health threats

The 100 Days Mission: how a new medical-countermeasures network can deliver equity and innovation

Adamantane resistance among influenza A viruses isolated early during the 2005-2006 influenza season in the United States

Influenza virus-like particles elicit broader immune responses than whole virion inactivated influenza virus or recombinant hemagglutinin

Impact of glycosylation on the immunogenicity of a DNA-based influenza H5 HA vaccine

Safety and immunogenicity of influenza A(H5N1) vaccine stored up to twelve years in the National Pre-Pandemic Influenza Vaccine Stockpile (NPIVS)

Seasonal influenza vaccination is associated with reduced risk of death among Medicare beneficiaries

Meeting the Challenges of Sepsis in Severe Coronavirus Disease 2019: A Call to Arms

H5N1 VLP vaccine induced protection in ferrets against lethal challenge with highly pathogenic H5N1 influenza viruses

Suchergebnisse filtern